medRxiv (Cold Spring Harbor Laboratory),
Год журнала:
2024,
Номер
unknown
Опубликована: Окт. 30, 2024
Abstract
OBJECTIVES
With
disease-modifying
drugs
for
degenerative
ataxias
on
the
horizon,
ecologically
valid
measures
of
motor
performance
that
can
detect
patient-relevant
changes
in
short,
trial-like
time
frames
are
highly
warranted.
In
this
2-year
longitudinal
study,
we
aimed
to
unravel
and
evaluate
ataxic
gait
which
sensitive
patients’
real
life
by
using
wearable
sensors.
METHODS
We
assessed
26
participants
with
cerebellar
disease
(SARA:9.4±4.1)
at
baseline,
1-year
follow-up
assessment
3
body-worn
inertial
sensors
two
conditions:
(1)
laboratory-based
walking
(LBW);
(2)
real-life
(RLW)
during
everyday
living.
RLW
condition,
a
context-sensitive
analysis
was
performed
selecting
comparable
bouts
according
macroscopic
characteristics,
namely
bout
length
number
turns
within
two-minute
interval.
Movement
focussed
spatio-temporal
variability,
particular
stride
lateral
step
deviation,
compound
measure
spatial
variability
(
SPCmp
).
RESULTS
Gait
showed
high
test-retest
reliability
both
conditions
(ICC
>
0.82).
Cross-sectional
analyses
revealed
correlations
ataxia
severity
(SARA,
effect
size
ρ≥0.75);
subjective
balance
confidence
(ABC
score,
ρ≥0.71),
here
achieving
higher
sizes
than
lab-based
(e.g.
:
ρ=0.81
vs
LBW
ρ=0.71).
While
clinician-reported
outcome
SARA
only
after
years,
already
one
year
(r
prb
=0.80).
subgroup
spinocerebellar
type
1,
2
or
(SCA1/2/3),
even
=0.86).
Based
these
sizes,
sample
estimation
required
cohort
n=42
(n=38
SCA
1/2/3
subgroup)
detecting
50%
reduction
natural
progression
hypothetical
intervention,
compared
n=254
SARA.
CONCLUSIONS
sensitivity
change
constrained
as
well
walking.
Due
their
ecological
validity
larger
characteristics
recordings
promising
outcomes
future
treatment
trials.
Frontiers in Pharmacology,
Год журнала:
2024,
Номер
15
Опубликована: Март 19, 2024
Quantitative
measurement
of
physical
activity
may
complement
neurological
evaluation
and
provide
valuable
information
on
patients’
daily
life.
We
evaluated
longitudinal
changes
in
patients
with
Friedreich
ataxia
(FRDA)
using
remote
monitoring
wearable
sensors.
performed
an
observational
study
26
adult
FRDA
13
age-sex
matched
healthy
controls
(CTR).
Participants
were
asked
to
wear
two
sensors,
at
non-dominant
wrist
waist,
for
7
days
during
waking
hours.
Evaluations
baseline
1-year
follow-up.
analysed
the
percentage
time
spent
sedentary
or
activities,
Vector
Magnitude
3
axes
(VM3),
average
number
steps/min.
Study
participants
also
clinical
scales
functional
tests
upper
limbs
dexterity
walking
capability.
Baseline
data
showed
that
had
overall
reduced
level
as
compared
CTR.
Accelerometer-based
measures
highly
correlated
disease
duration
FRDA.
Significantly
from
l-year
follow-up
observed
following
measures:
(i)
VM3;
(ii)
light
activity,
(iii)
Moderate-Vigorous
Physical
Activity
(MVPA).
Reduction
corresponded
worsening
gait
score
Scale
Assessment
Rating
Ataxia.
Real-life
is
feasible
well
tolerated
by
patients.
can
quantify
progression
over
1
year,
providing
objective
about
patient’s
motor
activities
supporting
usefulness
these
complementary
outcome
measure
interventional
trials.
Journal of Parkinson s Disease,
Год журнала:
2025,
Номер
unknown
Опубликована: Фев. 25, 2025
Background
Research
over
the
past
twenty
years
has
shown
that
gait
outcomes
have
a
high
sensitivity
for
diagnosing
Parkinson's
disease
(PD),
detecting
effects
of
interventions,
and
monitoring
progression,
even
in
early
disease.
However,
lack
standardization
protocols
reported
measures
is
impeding
data
aggregation
across
study
sites
contributes
to
heterogeneity
results,
thus
limiting
adoption
clinical
trials.
Objective
To
provide
recommendations
minimum
set
be
adopted
projects
evaluating
people
with
PD
enhance
field.
Methods
The
Gait
Advisors
Leading
Outcomes
(GALOP)
committee
an
advisory
MJFF.
Based
on
five-step
approach,
GALOP
generated
standardizing
assess
quantitative
measures,
following
expert
consensus
best
practices.
Results
Built
literature
amongst
experts,
we
recommend
meta-data
accompany
assessment
protocol
performed
at
comfortable
speed.
Suggestions
challenging
testing
are
provided.
Conclusions
support
empower
scientific
community,
collect
share
gathered
from
using
open
repository.
Standardizing
potential
accelerating
research
trials,
harmonizing
sites,
fostering
collaborations,
long
run,
improving
patient
care
quality
life.
Abstract
Cerebellar
extinction
lesions
can
manifest
themselves
with
cerebellar
motor
and
cognitive
affective
syndromes.
For
investigation
of
the
functions
cerebellum
pathogenesis
diseases,
particularly
hereditary
neurodegenerative
ataxias,
various
mutant
mice
are
used.
The
Lurcher
mouse
is
a
model
selective
olivocerebellar
degeneration
early
onset
rapid
progress.
These
show
both
deficits
as
well
behavioral
changes
i.e.,
pathological
phenotype
in
functional
domains
affected
patients.
Therefore,
might
be
considered
tool
to
investigate
mechanisms
impairments
caused
by
degenerative
diseases.
There
are,
however,
limitations
due
particular
features
process
lack
possibilities
examine
some
processes
mice.
main
advantage
would
expected
absence
significant
neuropathologies
outside
system
that
modify
complex
less
models.
However,
detailed
examinations
further
thorough
validation
needed
verify
this
assumption.
Sensors,
Год журнала:
2025,
Номер
25(6), С. 1764 - 1764
Опубликована: Март 12, 2025
Severe
traumatic
brain
injury
(sTBI)
often
results
in
significant
impairments
gait
stability,
symmetry,
and
smoothness.
Inertial
measurement
units
(IMUs)
have
emerged
as
powerful
tools
to
quantify
these
aspects
of
gait,
but
their
clinometric
properties
sTBI
populations
remain
underexplored.
This
study
aimed
assess
the
test-retest
reliability
minimal
detectable
change
(MDC)
three
IMU-derived
indices—normalized
Root
Mean
Square
(nRMS),
improved
Harmonic
Ratio
(iHR),
Log
Dimensionless
Jerk
(LDLJ)—during
a
10
m
walking
test
for
survivors.
Forty-nine
participants
with
completed
test,
IMUs
placed
on
key
body
segments
capture
accelerations
angular
velocities.
Test-retest
analyses
revealed
moderate
excellent
nRMS
iHR
anteroposterior
(ICC:
0.78–0.95
0.94,
respectively)
craniocaudal
directions
0.95),
small
MDC
values,
supporting
clinical
applicability
(MDC:
0.04–0.3).
However,
mediolateral
direction
exhibited
greater
variability
0.80;
MDC:
9.74),
highlighting
potential
sensitivity
challenges.
LDLJ
metrics
showed
0.57–0.77)
higher
values
(0.55–0.75),
suggesting
need
further
validation.
These
findings
underscore
specific
indices
detecting
meaningful
changes
survivors,
paving
way
refined
assessments
monitoring
rehabilitation
process
Future
research
should
explore
indices’
responsiveness
interventions
correlation
functional
outcomes.
Abstract
Effective
trial-planning
in
Spastic
ataxias
(SPAX)
is
impeded
by
the
absence
of
validated
outcome
measures
for
detecting
longitudinal
changes.
Digital
show
promise,
demonstrating
sensitivity
to
disease
severity
changes
ataxia
and
strong
correlations
with
clinical
scales.
The
objective
this
study
was
develop
a
smartphone
application
SPAX
(SPAX-app)
obtain
valid
digital
use
trials.
app
contains
four
tasks
assessing
gait,
standing
balance
(stance),
finger
hand
movements.
We
carried
out
validation
22
patients
10
controls.
Subjects
performed
three
times
during
one
visit.
In
parallel,
we
Ambulatory
Parkinson’s
Disease
Monitoring
(APDM)
sensor
recordings,
Q-motor
upper
limb
assessment,
Scale
Assessment
Rating
Ataxia
(SARA).
Significant
were
found
between
SPAX-app
APDM
or
step
time
(
r
=
0.91),
all
stance
0.51–0.87)
duration
alternation
0.64).
No
significant
variability
(e.g.
standard
deviation
time).
All
SPAX-app,
except
stance,
can
discriminate
from
controls
moderate
high
test-retest
reliability
(ICC
0.67–0.97).
SARA
0.70),
inter-onset
interval
tapping
0.57),
0.65).
task
did
not
SARA.
With
present
set
potential
Longitudinal
studies
are
needed
evaluate
whether
these
track
progression.
Movement Disorders Clinical Practice,
Год журнала:
2024,
Номер
11(6), С. 666 - 675
Опубликована: Апрель 2, 2024
Core
stability
exercises
(CSE)
have
been
shown
to
be
effective
in
improving
trunk
function
several
neurological
diseases,
but
the
evidence
is
scarce
on
Hereditary
Ataxias
(HA).